Inquiry Basket
MCC, or microcrystalline cellulose, is a widely recognized and esteemed compound in the biomedical realm, serving as an essential excipient within pharmaceutical formulations. Its pervasive employment focuses on augmenting drug stability, regulating release kinetics, and fortifying tablet attributes. By virtue of its multifarious benefits, MCC assumes a pivotal role in the fabrication of tablets, capsules, and granules encompassing diverse pharmacological agents, including analgesics, antihypertensives, and antidiabetic substances. Furthermore, MCC actively contributes to the amelioration of certain gastrointestinal afflictions, while simultaneously manifesting as an efficacious binder in manifold solid dosage formulations.
| Catalog Number | Size | Price | Quantity | |
|---|---|---|---|---|
| BADC-01506 | -- | $-- | Inquiry |
MCC, or Maleimidocaproyl, is a widely used linker in antibody-drug conjugates (ADCs). This linker has a profound impact in the field of biopharmaceuticals, especially in cancer treatment. ADCs achieve high-efficiency targeted therapy by delivering potent drugs specifically to tumor cells, significantly improving treatment effectiveness while reducing side effects on healthy cells.
One of the key roles of MCC in ADCs is serving as a stable chemical linker. The function of a chemical linker in ADCs is to secure the cytotoxic drug to the antibody through chemical bonds and release the drug upon reaching the target cell. MCC achieves stable chemical bonding through its maleimide group, which reacts with thiol groups on antibodies. This bonding ensures the stability of the drug in blood circulation and enables the release of active drugs in specific environments, such as in tumor cells under certain enzymatic or reductive conditions.
Additionally, the design of the MCC linker offers high customizability. This feature allows scientists to adjust the linker’s length, molecular size, hydrophilicity, and hydrophobicity, optimizing the pharmacokinetic properties and target cell uptake rate of ADCs. By modifying the MCC linker, one can enhance the circulation time of ADCs in the body, increase targeting effects, and reduce potential immunogenic responses. This provides flexibility for the development of different types of cancer treatments and personalized therapy strategies.
In clinical applications, drugs using MCC as an ADC linker have achieved certain successes. Medications like Kadcyla™ (ado-trastuzumab emtansine) are successful cases utilizing MCC linkers. These drugs have demonstrated significant efficacy, particularly in difficult-to-treat metastatic breast cancer, showcasing the potential of MCC linkers in actual therapies. Their successful use has also spurred more ADC-based drug development projects, enhancing the overall quality of cancer treatments.
However, there are challenges in using MCC linkers, such as premature cleavage or non-specific drug release in complex biological environments. To address these issues, researchers continually work to improve the design and synthesis of MCC linkers, striving to enhance selectivity and safety without compromising efficacy. These efforts not only advance the application of MCC as an ADC linker but also promote innovation in related chemical and biological technologies.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
